Carcharodon carcharias isolate sCarCar2 chromosome 28, sCarCar2.pri, whole genome shotgun sequence.
Carcharodon carcharias (great white shark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Lamniformes; Alopiidae; Carcharodon.
REFSEQ INFORMATION: The reference sequence is identical to\nCM029992.1.\nAssembly name: sCarCar2.pri\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/03/30. The original whole-genome shotgun project has the\naccession JAGDEE000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 05-FEB-2021\nAssembly Method :: FALCON v. DX 2.0.1; FALCON-Unzip v. DX\n 1.2.1; purge_dups v. DX 19-08-10;\n scaff10X v. DX 2.0.3; bionano Solve v. DX\n 3.4.0; Salsa2 HiC v. DX 2.2.0; Arrow\n polishing and gap filling v. DX 7.0.1.1;\n Longranger Align DX v. 2.2.2.1; freebayes\n DX v. 19-07-11; gEVAL manual curation v.\n 2021-02-05; VGP assembly pipeline v. 1.6\nAssembly Name :: sCarCar2.pri\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 66.84x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Carcharodon carcharias Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 8.6\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
BMS1 ribosome biogenesis factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
BMS1 ribosome biogenesis factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ribosome biogenesis protein BMS1 homolog isoform X2
ribosome biogenesis protein BMS1 homolog isoform X1
protein FAM149B1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein FAM149B1-like, transcript variant X4
protein FAM149B1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein FAM149B1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein FAM149B1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein FAM149B1-like, transcript variant X2
primary cilium assembly protein FAM149B1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DnaJ (Hsp40) homolog, subfamily C, member 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DnaJ (Hsp40) homolog, subfamily C, member 9, transcript variant X1
DnaJ (Hsp40) homolog, subfamily C, member 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear factor NF-kappa-B p100 subunit-like
leucine-rich repeat-containing protein 20-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine-rich repeat-containing protein 20-like, transcript variant X1
leucine-rich repeat-containing protein 20-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat-containing protein 20-like isoform X1
leucine-rich repeat-containing protein 20-like isoform X2
transforming growth factor beta regulator 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transforming growth factor beta regulator 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transforming growth factor beta regulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transforming growth factor beta regulator 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transforming growth factor beta regulator 1, transcript variant X7
transforming growth factor beta regulator 1 isoform X1
transforming growth factor beta regulator 1 isoform X2
transforming growth factor beta regulator 1 isoform X3
transforming growth factor beta regulator 1 isoform X6
transforming growth factor beta regulator 1, transcript variant X5
transforming growth factor beta regulator 1, transcript variant X4
transforming growth factor beta regulator 1 isoform X4
transforming growth factor beta regulator 1 isoform X5
transforming growth factor beta regulator 1 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
polyunsaturated fatty acid 5-lipoxygenase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
fatty acid-binding protein, intestinal-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fatty acid-binding protein, intestinal-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
fatty acid-binding protein, intestinal-like
phosphoinositide-3-kinase adaptor protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphoinositide-3-kinase adaptor protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
phosphoinositide 3-kinase adapter protein 1 isoform X2
phosphoinositide 3-kinase adapter protein 1 isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X3
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X3
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01229
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
sorbin and SH3 domain-containing protein 1-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X15
sorbin and SH3 domain-containing protein 1-like, transcript variant X37
sorbin and SH3 domain-containing protein 1-like, transcript variant X35
sorbin and SH3 domain-containing protein 1-like, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X1
sorbin and SH3 domain-containing protein 1-like, transcript variant X18
sorbin and SH3 domain-containing protein 1-like, transcript variant X5
sorbin and SH3 domain-containing protein 1-like, transcript variant X16
sorbin and SH3 domain-containing protein 1-like, transcript variant X4
sorbin and SH3 domain-containing protein 1-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X24
sorbin and SH3 domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X6
sorbin and SH3 domain-containing protein 1-like, transcript variant X8
sorbin and SH3 domain-containing protein 1-like, transcript variant X14
sorbin and SH3 domain-containing protein 1-like, transcript variant X11
sorbin and SH3 domain-containing protein 1-like, transcript variant X7
sorbin and SH3 domain-containing protein 1-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X19
sorbin and SH3 domain-containing protein 1-like, transcript variant X23
sorbin and SH3 domain-containing protein 1-like, transcript variant X30
sorbin and SH3 domain-containing protein 1-like, transcript variant X2
sorbin and SH3 domain-containing protein 1-like, transcript variant X32
sorbin and SH3 domain-containing protein 1-like, transcript variant X22
sorbin and SH3 domain-containing protein 1-like, transcript variant X26
sorbin and SH3 domain-containing protein 1-like, transcript variant X27
sorbin and SH3 domain-containing protein 1-like, transcript variant X28
sorbin and SH3 domain-containing protein 1-like, transcript variant X29
sorbin and SH3 domain-containing protein 1-like, transcript variant X31
sorbin and SH3 domain-containing protein 1-like, transcript variant X33
sorbin and SH3 domain-containing protein 1-like isoform X1
sorbin and SH3 domain-containing protein 1-like isoform X12
sorbin and SH3 domain-containing protein 1-like isoform X18
sorbin and SH3 domain-containing protein 1-like isoform X22
sorbin and SH3 domain-containing protein 1-like isoform X28
sorbin and SH3 domain-containing protein 1-like isoform X29
sorbin and SH3 domain-containing protein 1-like isoform X16
sorbin and SH3 domain-containing protein 1-like isoform X2
sorbin and SH3 domain-containing protein 1-like isoform X30
sorbin and SH3 domain-containing protein 1-like isoform X17
sorbin and SH3 domain-containing protein 1-like isoform X31
sorbin and SH3 domain-containing protein 1-like isoform X5
sorbin and SH3 domain-containing protein 1-like isoform X15
sorbin and SH3 domain-containing protein 1-like isoform X4
sorbin and SH3 domain-containing protein 1-like isoform X11
sorbin and SH3 domain-containing protein 1-like isoform X19
sorbin and SH3 domain-containing protein 1-like isoform X23
sorbin and SH3 domain-containing protein 1-like isoform X3
sorbin and SH3 domain-containing protein 1-like isoform X6
sorbin and SH3 domain-containing protein 1-like isoform X8
sorbin and SH3 domain-containing protein 1-like isoform X13
sorbin and SH3 domain-containing protein 1-like isoform X21
sorbin and SH3 domain-containing protein 1-like isoform X25
sorbin and SH3 domain-containing protein 1-like isoform X26
sorbin and SH3 domain-containing protein 1-like isoform X27
sorbin and SH3 domain-containing protein 1-like isoform X32
sorbin and SH3 domain-containing protein 1-like isoform X10
sorbin and SH3 domain-containing protein 1-like isoform X7
sorbin and SH3 domain-containing protein 1-like, transcript variant X21
sorbin and SH3 domain-containing protein 1-like, transcript variant X36
sorbin and SH3 domain-containing protein 1-like, transcript variant X10
sorbin and SH3 domain-containing protein 1-like isoform X9
sorbin and SH3 domain-containing protein 1-like isoform X20
sorbin and SH3 domain-containing protein 1-like isoform X14
sorbin and SH3 domain-containing protein 1-like, transcript variant X34
sorbin and SH3 domain-containing protein 1-like isoform X34
sorbin and SH3 domain-containing protein 1-like isoform X33
sorbin and SH3 domain-containing protein 1-like, transcript variant X25
sorbin and SH3 domain-containing protein 1-like, transcript variant X38
sorbin and SH3 domain-containing protein 1-like isoform X35
sorbin and SH3 domain-containing protein 1-like isoform X24
PDZ and LIM domain 1 (elfin), transcript variant X1
PDZ and LIM domain 1 (elfin), transcript variant X2
paired box protein Pax-2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins
paired box protein Pax-2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins
paired box protein Pax-2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins
paired box protein Pax-2, transcript variant X5
paired box protein Pax-2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins
carbohydrate sulfotransferase 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
carbohydrate sulfotransferase 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
carbohydrate sulfotransferase 3-like, transcript variant X1
growth hormone inducible transmembrane protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
growth hormone-inducible transmembrane protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins
membrane-associated ring finger (C3HC4) 8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
zinc finger, AN1-type domain 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger, AN1-type domain 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger, AN1-type domain 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger, AN1-type domain 4, transcript variant X4
AN1-type zinc finger protein 4 isoform X2
AN1-type zinc finger protein 4 isoform X1
AN1-type zinc finger protein 4 isoform X3
WASH complex subunit 2C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
WASH complex subunit 2C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WASH complex subunit 2C, transcript variant X7
WASH complex subunit 2C, transcript variant X9
WASH complex subunit 2C, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
WASH complex subunit 2C, transcript variant X8
WASH complex subunit 2C, transcript variant X4
WASH complex subunit 2C, transcript variant X6
WASH complex subunit 2C, transcript variant X1
WASH complex subunit 2C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 6% coverage of the annotated genomic feature by RNAseq alignments
LIM domain-binding protein 3-like, transcript variant X6
LIM domain-binding protein 3-like, transcript variant X7
LIM domain-binding protein 3-like, transcript variant X9
LIM domain-binding protein 3-like, transcript variant X2
LIM domain-binding protein 3-like, transcript variant X1
LIM domain-binding protein 3-like, transcript variant X3
LIM domain-binding protein 3-like, transcript variant X5
LIM domain-binding protein 3-like, transcript variant X4
LIM domain-binding protein 3-like, transcript variant X8
LIM domain-binding protein 3-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
LIM domain-binding protein 3-like isoform X1
LIM domain-binding protein 3-like isoform X3
LIM domain-binding protein 3-like isoform X2
LIM domain-binding protein 3-like isoform X6
LIM domain-binding protein 3-like isoform X4
LIM domain-binding protein 3-like isoform X5
LIM domain-binding protein 3-like isoform X7
LIM domain-binding protein 3-like isoform X8
bone morphogenetic protein receptor, type IAa, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 121 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
bone morphogenetic protein receptor, type IAa, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 121 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bone morphogenetic protein receptor, type IAa, transcript variant X2
bone morphogenetic protein receptor, type IAa, transcript variant X4
bone morphogenetic protein receptor, type IAa, transcript variant X5
bone morphogenetic protein receptor, type IAa
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
shieldin complex subunit 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
shieldin complex subunit 2, transcript variant X6
shieldin complex subunit 2, transcript variant X4
shieldin complex subunit 2, transcript variant X1
shieldin complex subunit 2, transcript variant X7
shieldin complex subunit 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
shieldin complex subunit 2, transcript variant X3
shieldin complex subunit 2, transcript variant X2
uncharacterized LOC121270909, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC121270909, transcript variant X2
uncharacterized LOC121270909, transcript variant X5
uncharacterized LOC121270909, transcript variant X1
uncharacterized LOC121270909, transcript variant X3
uncharacterized protein LOC561476 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC561476 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC561476 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein LOC561476 homolog, transcript variant X2
translocase of inner mitochondrial membrane 23 homolog a (yeast), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitochondrial import inner membrane translocase subunit Tim23 isoform X1
translocase of inner mitochondrial membrane 23 homolog a (yeast), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitochondrial import inner membrane translocase subunit Tim23 isoform X2
nuclear receptor coactivator 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nuclear receptor coactivator 4, transcript variant X3
nuclear receptor coactivator 4, transcript variant X1
nuclear receptor coactivator 4 isoform X2
nuclear receptor coactivator 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
L-threonine ammonia-lyase, transcript variant X1
L-threonine ammonia-lyase, transcript variant X2
transmembrane protein 254, transcript variant X4
transmembrane protein 254, transcript variant X2
transmembrane protein 254, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
transmembrane protein 254, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transmembrane protein 254, transcript variant X5
transmembrane protein 254, transcript variant X1
transmembrane protein 254, transcript variant X7
transmembrane protein 254, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 254, transcript variant X6
transmembrane protein 254, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CUE domain-containing protein 2-A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CUE domain-containing protein 2-A-like, transcript variant X2
CUE domain-containing protein 2-A-like, transcript variant X3
F-box and leucine-rich repeat protein 15, transcript variant X1
F-box and leucine-rich repeat protein 15, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
F-box and leucine-rich repeat protein 15, transcript variant X2
hypoxia inducible factor 1 subunit alpha inhibitor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hypoxia inducible factor 1 subunit alpha inhibitor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
hypoxia inducible factor 1 subunit alpha inhibitor, transcript variant X2
hypoxia-inducible factor 1-alpha inhibitor isoform X1
hypoxia-inducible factor 1-alpha inhibitor isoform X2
NADH:ubiquinone oxidoreductase subunit B8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial
SEC31 homolog B, COPII coat complex component, transcript variant X3
SEC31 homolog B, COPII coat complex component, transcript variant X1
SEC31 homolog B, COPII coat complex component, transcript variant X5
SEC31 homolog B, COPII coat complex component, transcript variant X2
SEC31 homolog B, COPII coat complex component, transcript variant X4
protein transport protein Sec31A isoform X1
protein transport protein Sec31A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transmembrane protein 150A-like, transcript variant X2
transmembrane protein 150A-like, transcript variant X1
transmembrane protein 150A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transmembrane protein 150A-like isoform X1
transmembrane protein 150A-like isoform X2
uncharacterized protein LOC796266 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 4E-binding protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
eukaryotic translation initiation factor 4E-binding protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
eukaryotic translation initiation factor 4E-binding protein 2-like, transcript variant X1
eukaryotic translation initiation factor 4E-binding protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 14, transcript variant X1
A disintegrin and metalloproteinase with thrombospondin motifs 14, transcript variant X2
A disintegrin and metalloproteinase with thrombospondin motifs 3 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 14 isoform X2
steroidogenic acute regulatory protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
microsomal triglyceride transfer protein large subunit-like, transcript variant X1
microsomal triglyceride transfer protein large subunit-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
microsomal triglyceride transfer protein large subunit-like isoform X1
microsomal triglyceride transfer protein large subunit-like isoform X2
pyroglutamylated RF-amide peptide receptor-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
AP2-associated protein kinase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
AP2-associated protein kinase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
AP2-associated protein kinase 1-like isoform X1
AP2-associated protein kinase 1-like isoform X2
AP2-associated protein kinase 1-like, transcript variant X3
AP2-associated protein kinase 1-like, transcript variant X4
AP2-associated protein kinase 1-like, transcript variant X5
AP2-associated protein kinase 1-like isoform X3
AP2-associated protein kinase 1-like isoform X4
progestin and adipoQ receptor family member 3-like, transcript variant X5
progestin and adipoQ receptor family member 3-like, transcript variant X2
progestin and adipoQ receptor family member 3-like, transcript variant X4
progestin and adipoQ receptor family member 3-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
progestin and adipoQ receptor family member 3-like, transcript variant X1
progestin and adipoQ receptor family member 3-like, transcript variant X3
progestin and adipoQ receptor family member 3-like isoform X2
progestin and adipoQ receptor family member 3-like isoform X1
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like, transcript variant X1
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like, transcript variant X2
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like isoform X1
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like isoform X2
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 20-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein phosphatase non-receptor type 20-like, transcript variant X2
tyrosine-protein phosphatase non-receptor type 20-like isoform X1
tyrosine-protein phosphatase non-receptor type 20-like isoform X2
tyrosine-protein phosphatase non-receptor type 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
mitogen-activated protein kinase 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 103 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitogen-activated protein kinase 8, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitogen-activated protein kinase 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 103 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mitogen-activated protein kinase 8 isoform X1
mitogen-activated protein kinase 8 isoform X2
rho GTPase-activating protein 22-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
rho GTPase-activating protein 22-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
rho GTPase-activating protein 22-like, transcript variant X3
rho GTPase-activating protein 22-like, transcript variant X4
rho GTPase-activating protein 22-like isoform X1
rho GTPase-activating protein 22-like isoform X2
rho GTPase-activating protein 22-like isoform X3
rho GTPase-activating protein 22-like isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
palmitoyltransferase AKR1, transcript variant X3
palmitoyltransferase AKR1, transcript variant X1
palmitoyltransferase AKR1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
WD repeat- and FYVE domain-containing protein 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat-containing protein 18
V-set and transmembrane domain containing 4a, transcript variant X2
V-set and transmembrane domain containing 4a, transcript variant X1
V-set and transmembrane domain-containing protein 4a isoform X2
V-set and transmembrane domain-containing protein 4a isoform X1
V-set and transmembrane domain containing 4a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
V-set and transmembrane domain-containing protein 4a isoform X3
transmembrane protein 273-like, transcript variant X1
transmembrane protein 273-like, transcript variant X2
transmembrane protein 273-like isoform X1
transmembrane protein 273-like isoform X2
cardiac-enriched FHL2-interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cardiac-enriched FHL2-interacting protein, transcript variant X1
cardiac-enriched FHL2-interacting protein, transcript variant X3
cardiac-enriched FHL2-interacting protein
dorsal root ganglia homeobox, transcript variant X2
dorsal root ganglia homeobox, transcript variant X1
dorsal root ganglia homeobox protein isoform X1
dorsal root ganglia homeobox protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
excision repair cross-complementation group 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
excision repair cross-complementation group 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
excision repair cross-complementation group 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DNA excision repair protein ERCC-6 isoform X1
DNA excision repair protein ERCC-6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
Ras association domain family member 4a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Ras association domain family member 4a, transcript variant X1
Ras association domain family member 4a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Ras association domain family member 4a, transcript variant X3
Ras association domain family member 4a, transcript variant X5
ras association domain-containing protein 4a
peroxisomal N(1)-acetyl-spermine/spermidine oxidase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
peroxisomal N(1)-acetyl-spermine/spermidine oxidase, transcript variant X2
peroxisomal N(1)-acetyl-spermine/spermidine oxidase
mitochondrial ribosome-associated GTPase 1, transcript variant X1
mitochondrial ribosome-associated GTPase 1, transcript variant X3
mitochondrial ribosome-associated GTPase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
mitochondrial ribosome-associated GTPase 1 isoform X1
mitochondrial ribosome-associated GTPase 1 isoform X3
mitochondrial ribosome-associated GTPase 1 isoform X2
enoyl CoA hydratase, short chain, 1, mitochondrial
fucose mutarotase, transcript variant X1
fucose mutarotase, transcript variant X2
calcyon neuron-specific vesicular protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tubulin, gamma complex associated protein 2, transcript variant X2
tubulin, gamma complex associated protein 2, transcript variant X1
gamma-tubulin complex component 2 isoform X1
gamma-tubulin complex component 2 isoform X2
zinc metalloproteinase-disintegrin-like crotastatin, transcript variant X1
zinc metalloproteinase-disintegrin-like crotastatin, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 8-like isoform X1
zinc metalloproteinase-disintegrin-like crotastatin isoform X2
catechol-O-methyltransferase domain containing 1, transcript variant X1
catechol O-methyltransferase domain-containing protein 1 isoform X1
catechol-O-methyltransferase domain containing 1, transcript variant X2
catechol O-methyltransferase domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 108 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 108 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
voltage-dependent anion-selective channel protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sterile alpha motif domain containing 8, transcript variant X1
sterile alpha motif domain containing 8, transcript variant X2
sterile alpha motif domain containing 8, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sterile alpha motif domain containing 8, transcript variant X3
sphingomyelin synthase-related protein 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
probable rhodanese domain-containing dual specificity protein phosphatase
dual specificity protein phosphatase 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins
K(lysine) acetyltransferase 6B, transcript variant X1
K(lysine) acetyltransferase 6B, transcript variant X2
histone acetyltransferase KAT6B isoform X1
histone acetyltransferase KAT6B isoform X2
adenosine kinase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
adenosine kinase-like, transcript variant X1
adenosine kinase-like, transcript variant X3
AP-3 complex subunit mu-1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
AP-3 complex subunit mu-1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
tissue-type plasminogen activator-like, transcript variant X2
tissue-type plasminogen activator-like, transcript variant X1
tissue-type plasminogen activator-like isoform X2
tissue-type plasminogen activator-like isoform X1
component of inhibitor of nuclear factor kappa B kinase complex
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
inhibitor of nuclear factor kappa-B kinase subunit alpha
elongation of very long chain fatty acids protein 5-like, transcript variant X8
elongation of very long chain fatty acids protein 5-like, transcript variant X5
elongation of very long chain fatty acids protein 5-like, transcript variant X4
elongation of very long chain fatty acids protein 5-like, transcript variant X6
elongation of very long chain fatty acids protein 5-like, transcript variant X7
elongation of very long chain fatty acids protein 5-like, transcript variant X3
elongation of very long chain fatty acids protein 5-like, transcript variant X2
elongation of very long chain fatty acids protein 5-like, transcript variant X1
elongation of very long chain fatty acids protein 5-like, transcript variant X13
elongation of very long chain fatty acids protein 5-like, transcript variant X12
elongation of very long chain fatty acids protein 5-like, transcript variant X11
elongation of very long chain fatty acids protein 5-like, transcript variant X10
elongation of very long chain fatty acids protein 5-like, transcript variant X9
elongation of very long chain fatty acids protein 5-like isoform X1
elongation of very long chain fatty acids protein 5-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
zinc finger protein 503, transcript variant X5
zinc finger protein 503, transcript variant X4
zinc finger protein 503, transcript variant X2
zinc finger protein 503, transcript variant X3
zinc finger protein 503, transcript variant X1
leucine rich melanocyte differentiation associated, transcript variant X2
leucine rich melanocyte differentiation associated, transcript variant X5
leucine rich melanocyte differentiation associated, transcript variant X7
leucine rich melanocyte differentiation associated, transcript variant X4
leucine rich melanocyte differentiation associated, transcript variant X3
leucine rich melanocyte differentiation associated, transcript variant X1
leucine-rich melanocyte differentiation-associated protein isoform X1
leucine rich melanocyte differentiation associated, transcript variant X6
leucine-rich melanocyte differentiation-associated protein isoform X2
leucine rich melanocyte differentiation associated, transcript variant X8
leucine-rich melanocyte differentiation-associated protein isoform X3
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium-activated potassium channel subunit alpha-1a isoform X4
calcium-activated potassium channel subunit alpha-1a isoform X2
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X1
calcium-activated potassium channel subunit alpha-1a isoform X1
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X3
calcium-activated potassium channel subunit alpha-1a isoform X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00548
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
discs, large homolog 5a (Drosophila), transcript variant X15
discs, large homolog 5a (Drosophila), transcript variant X14
discs, large homolog 5a (Drosophila), transcript variant X1
discs, large homolog 5a (Drosophila), transcript variant X13
discs, large homolog 5a (Drosophila), transcript variant X7
discs, large homolog 5a (Drosophila), transcript variant X12
discs, large homolog 5a (Drosophila), transcript variant X11
discs, large homolog 5a (Drosophila), transcript variant X4
discs, large homolog 5a (Drosophila), transcript variant X10
discs, large homolog 5a (Drosophila), transcript variant X9
discs, large homolog 5a (Drosophila), transcript variant X5
discs, large homolog 5a (Drosophila), transcript variant X8
discs, large homolog 5a (Drosophila), transcript variant X6
discs, large homolog 5a (Drosophila), transcript variant X2
discs, large homolog 5a (Drosophila), transcript variant X3
elongation of very long chain fatty acids protein 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
ferroptosis suppressor protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ferroptosis suppressor protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2
leucine-rich repeat, immunoglobulin-like and transmembrane domains 1a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1a
retinal G protein coupled receptor a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
retinal G protein coupled receptor a isoform X1
retinal G protein coupled receptor a, transcript variant X2
retinal G protein coupled receptor a isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
probable vesicular acetylcholine transporter-A
choline O-acetyltransferase a, transcript variant X1
choline O-acetyltransferase a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
oxoglutarate dehydrogenase L, transcript variant X3
oxoglutarate dehydrogenase L, transcript variant X2
oxoglutarate dehydrogenase L, transcript variant X1
oxoglutarate dehydrogenase L, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
2-oxoglutarate dehydrogenase-like, mitochondrial
oxoglutarate dehydrogenase L, transcript variant X5
poly (ADP-ribose) glycohydrolase a, transcript variant X6
poly (ADP-ribose) glycohydrolase a, transcript variant X2
poly (ADP-ribose) glycohydrolase a, transcript variant X3
poly (ADP-ribose) glycohydrolase a, transcript variant X7
poly (ADP-ribose) glycohydrolase a, transcript variant X4
poly (ADP-ribose) glycohydrolase a, transcript variant X1
poly (ADP-ribose) glycohydrolase a, transcript variant X5
poly(ADP-ribose) glycohydrolase isoform X2
poly(ADP-ribose) glycohydrolase isoform X3
poly(ADP-ribose) glycohydrolase isoform X4
poly(ADP-ribose) glycohydrolase isoform X1
poly(ADP-ribose) glycohydrolase isoform X5
poly (ADP-ribose) glycohydrolase a, transcript variant X8
poly(ADP-ribose) glycohydrolase isoform X6
ribosomal protein S24, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ribosomal protein S24, transcript variant X2
ribosomal protein S24, transcript variant X3
ribosomal protein S24, transcript variant X7
ribosomal protein S24, transcript variant X6
ribosomal protein S24, transcript variant X9
ribosomal protein S24, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ribosomal protein S24, transcript variant X1
ribosomal protein S24, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
zinc finger, MIZ-type containing 1a, transcript variant X2
zinc finger, MIZ-type containing 1a, transcript variant X1
zinc finger, MIZ-type containing 1a, transcript variant X4
zinc finger, MIZ-type containing 1a, transcript variant X5
zinc finger, MIZ-type containing 1a, transcript variant X3
zinc finger, MIZ-type containing 1a, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
zinc finger, MIZ-type containing 1a, transcript variant X6
zinc finger, MIZ-type containing 1a, transcript variant X8
zinc finger MIZ domain-containing protein 1a isoform X1
zinc finger MIZ domain-containing protein 1a isoform X3
zinc finger MIZ domain-containing protein 1a isoform X4
zinc finger MIZ domain-containing protein 1a isoform X2
zinc finger MIZ domain-containing protein 1a isoform X9
zinc finger MIZ domain-containing protein 1a isoform X5
zinc finger MIZ domain-containing protein 1a isoform X7
zinc finger, MIZ-type containing 1a, transcript variant X14
zinc finger, MIZ-type containing 1a, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger, MIZ-type containing 1a, transcript variant X10
zinc finger, MIZ-type containing 1a, transcript variant X9
zinc finger, MIZ-type containing 1a, transcript variant X13
zinc finger, MIZ-type containing 1a, transcript variant X15
zinc finger, MIZ-type containing 1a, transcript variant X16
zinc finger, MIZ-type containing 1a, transcript variant X7
zinc finger MIZ domain-containing protein 1a isoform X6
zinc finger, MIZ-type containing 1a, transcript variant X17
zinc finger, MIZ-type containing 1a, transcript variant X11
zinc finger MIZ domain-containing protein 1a isoform X8
peptidyl-prolyl cis-trans isomerase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 36% coverage of the annotated genomic feature by RNAseq alignments
peptidyl-prolyl cis-trans isomerase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 104 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase-like isoform X2
peptidyl-prolyl cis-trans isomerase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 165 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase-like isoform X1
zinc finger, CCHC domain containing 24, transcript variant X1
zinc finger, CCHC domain containing 24, transcript variant X2
zinc finger, CCHC domain containing 24, transcript variant X3
zinc finger CCHC domain-containing protein 24 isoform X3
zinc finger CCHC domain-containing protein 24 isoform X1
zinc finger CCHC domain-containing protein 24 isoform X2
pro-neuregulin-3, membrane-bound isoform-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
wings apart-like protein homolog, transcript variant X1
wings apart-like protein homolog, transcript variant X2
neurogenic differentiation factor 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62% coverage of the annotated genomic feature by RNAseq alignments
glutamate receptor ionotropic, delta-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 30% coverage of the annotated genomic feature by RNAseq alignments
serine-rich coiled-coil domain-containing protein 2-like, transcript variant X2
serine-rich coiled-coil domain-containing protein 2-like, transcript variant X1
serine-rich coiled-coil domain-containing protein 2-like isoform X2
serine-rich coiled-coil domain-containing protein 2-like isoform X1
serine-rich coiled-coil domain-containing protein 2-like, transcript variant X3
serine-rich coiled-coil domain-containing protein 2-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
SEC24 homolog C, COPII coat complex component, transcript variant X1
SEC24 homolog C, COPII coat complex component, transcript variant X2
SEC24 homolog C, COPII coat complex component, transcript variant X3
protein transport protein Sec24C isoform X2
protein transport protein Sec24C isoform X1
ubiquitin specific peptidase 54a, transcript variant X8
ubiquitin specific peptidase 54a, transcript variant X9
ubiquitin specific peptidase 54a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ubiquitin specific peptidase 54a, transcript variant X7
ubiquitin specific peptidase 54a, transcript variant X5
ubiquitin specific peptidase 54a, transcript variant X4
ubiquitin specific peptidase 54a, transcript variant X6
ubiquitin specific peptidase 54a, transcript variant X3
ubiquitin specific peptidase 54a, transcript variant X2
inactive ubiquitin carboxyl-terminal hydrolase 54a isoform X5
inactive ubiquitin carboxyl-terminal hydrolase 54a isoform X1
inactive ubiquitin carboxyl-terminal hydrolase 54a isoform X3
inactive ubiquitin carboxyl-terminal hydrolase 54a isoform X2
inactive ubiquitin carboxyl-terminal hydrolase 54a isoform X4
inactive ubiquitin carboxyl-terminal hydrolase 54a isoform X6
inactive ubiquitin carboxyl-terminal hydrolase 54a isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 43% coverage of the annotated genomic feature by RNAseq alignments
collagen, type XIII, alpha 1, transcript variant X1
collagen, type XIII, alpha 1, transcript variant X11
collagen, type XIII, alpha 1, transcript variant X14
collagen, type XIII, alpha 1, transcript variant X13
collagen, type XIII, alpha 1, transcript variant X7
collagen, type XIII, alpha 1, transcript variant X3
collagen, type XIII, alpha 1, transcript variant X2
collagen, type XIII, alpha 1, transcript variant X5
collagen, type XIII, alpha 1, transcript variant X8
collagen, type XIII, alpha 1, transcript variant X9
collagen, type XIII, alpha 1, transcript variant X15
collagen, type XIII, alpha 1, transcript variant X12
collagen, type XIII, alpha 1, transcript variant X10
collagen, type XIII, alpha 1, transcript variant X6
collagen, type XIII, alpha 1, transcript variant X4
collagen alpha-1(XIII) chain isoform X11
collagen alpha-1(XIII) chain isoform X14
collagen alpha-1(XIII) chain isoform X13
collagen alpha-1(XIII) chain isoform X15
collagen alpha-1(XIII) chain isoform X12
collagen alpha-1(XIII) chain isoform X10
core histone macro-H2A.2, transcript variant X3
core histone macro-H2A.2, transcript variant X1
core histone macro-H2A.2, transcript variant X2
core histone macro-H2A.2, transcript variant X4
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X2
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X5
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X4
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X3
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X1
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X6
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X2
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X5
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X4
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X3
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X1
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
sphingosine-1-phosphate lyase 1, transcript variant X1
sphingosine-1-phosphate lyase 1 isoform X1
sphingosine-1-phosphate lyase 1, transcript variant X2
sphingosine-1-phosphate lyase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha
pterin-4-alpha-carbinolamine dehydratase
unc-5 netrin receptor B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
unc-5 netrin receptor B, transcript variant X2
solute carrier family 29 member 3, transcript variant X2
solute carrier family 29 member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
V-type immunoglobulin domain-containing suppressor of T-cell activation
calcium-binding mitochondrial carrier protein SCaMC-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium-binding mitochondrial carrier protein SCaMC-1-like, transcript variant X2
calcium-binding mitochondrial carrier protein SCaMC-1-like isoform X1
calcium-binding mitochondrial carrier protein SCaMC-1-like isoform X2
biogenesis of lysosomal organelles complex-1, subunit 2
biogenesis of lysosome-related organelles complex 1 subunit 2
heterogeneous nuclear ribonucleoprotein D-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
trypsin like peroxisomal matrix peptidase 1, transcript variant X3
trypsin like peroxisomal matrix peptidase 1, transcript variant X2
trypsin like peroxisomal matrix peptidase 1, transcript variant X1
peroxisomal leader peptide-processing protease isoform X1
peroxisomal leader peptide-processing protease isoform X2
peroxisomal leader peptide-processing protease isoform X3
DNA damage-inducible transcript 4 protein
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2, transcript variant X2
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2, transcript variant X1
activating signal cointegrator 1 complex subunit 1, transcript variant X1
activating signal cointegrator 1 complex subunit 1, transcript variant X2
activating signal cointegrator 1 complex subunit 1, transcript variant X3
activating signal cointegrator 1 complex subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member B12a
mitochondrial calcium uptake 1, transcript variant X2
mitochondrial calcium uptake 1, transcript variant X8
mitochondrial calcium uptake 1, transcript variant X11
mitochondrial calcium uptake 1, transcript variant X10
mitochondrial calcium uptake 1, transcript variant X1
mitochondrial calcium uptake 1, transcript variant X6
mitochondrial calcium uptake 1, transcript variant X5
mitochondrial calcium uptake 1, transcript variant X4
mitochondrial calcium uptake 1, transcript variant X3
mitochondrial calcium uptake 1, transcript variant X9
mitochondrial calcium uptake 1, transcript variant X7
calcium uptake protein 1, mitochondrial isoform X3
calcium uptake protein 1, mitochondrial isoform X2
calcium uptake protein 1, mitochondrial isoform X1
mitochondrial calcium uptake 1, transcript variant X12
calcium uptake protein 1, mitochondrial isoform X4
mitochondrial calcium uniporter, transcript variant X1
mitochondrial calcium uniporter, transcript variant X3
calcium uniporter protein, mitochondrial isoform X1
calcium uniporter protein, mitochondrial isoform X3
mitochondrial calcium uniporter, transcript variant X2
calcium uniporter protein, mitochondrial isoform X2
oncoprotein-induced transcript 3 protein
phospholipase A2, group XIIB, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
phospholipase A2, group XIIB, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
group XIIB secretory phospholipase A2-like protein isoform X2
group XIIB secretory phospholipase A2-like protein isoform X1
prolyl 4-hydroxylase, alpha polypeptide I b, transcript variant X6
prolyl 4-hydroxylase, alpha polypeptide I b, transcript variant X7
prolyl 4-hydroxylase, alpha polypeptide I b, transcript variant X9
prolyl 4-hydroxylase, alpha polypeptide I b, transcript variant X2
prolyl 4-hydroxylase, alpha polypeptide I b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
prolyl 4-hydroxylase, alpha polypeptide I b, transcript variant X8
prolyl 4-hydroxylase, alpha polypeptide I b, transcript variant X4
prolyl 4-hydroxylase, alpha polypeptide I b, transcript variant X3
prolyl 4-hydroxylase, alpha polypeptide I b, transcript variant X5
prolyl 4-hydroxylase subunit alpha-1b isoform X2
prolyl 4-hydroxylase subunit alpha-1b isoform X1
prolyl 4-hydroxylase subunit alpha-1b isoform X4
prolyl 4-hydroxylase subunit alpha-1b isoform X3
prolyl 4-hydroxylase subunit alpha-1b isoform X5
prolyl 4-hydroxylase subunit alpha-1b isoform X6
nudix (nucleoside diphosphate linked moiety X)-type motif 13, transcript variant X1
nucleoside diphosphate-linked moiety X motif 13 isoform X1
nudix (nucleoside diphosphate linked moiety X)-type motif 13, transcript variant X3
nudix (nucleoside diphosphate linked moiety X)-type motif 13, transcript variant X2
nudix (nucleoside diphosphate linked moiety X)-type motif 13, transcript variant X4
nudix (nucleoside diphosphate linked moiety X)-type motif 13, transcript variant X5
nucleoside diphosphate-linked moiety X motif 13 isoform X2
nucleoside diphosphate-linked moiety X motif 13 isoform X3
nucleoside diphosphate-linked moiety X motif 13 isoform X4
ecdysoneless homolog (Drosophila), transcript variant X2
ecdysoneless homolog (Drosophila), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
ret proto-oncogene receptor tyrosine kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 41% coverage of the annotated genomic feature by RNAseq alignments
proto-oncogene tyrosine-protein kinase receptor Ret
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X2
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X3
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X4
chondroitin sulfate N-acetylgalactosaminyltransferase 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
ras-GEF domain-containing family member 1A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ras-GEF domain-containing family member 1A-like, transcript variant X4
ras-GEF domain-containing family member 1A-like, transcript variant X3
ras-GEF domain-containing family member 1A-like, transcript variant X2
ras-GEF domain-containing family member 1A-like, transcript variant X5
ras-GEF domain-containing family member 1A-like isoform X2
ras-GEF domain-containing family member 1A-like isoform X1
ras-GEF domain-containing family member 1A-like isoform X3
PH and SEC7 domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
PH and SEC7 domain-containing protein 1-like, transcript variant X1
PH and SEC7 domain-containing protein 1-like, transcript variant X3
PH and SEC7 domain-containing protein 1-like isoform X2
PH and SEC7 domain-containing protein 1-like isoform X1
PH and SEC7 domain-containing protein 1-like isoform X3
fucosyltransferase 11 (alpha (1,3) fucosyltransferase), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fucosyltransferase 11 (alpha (1,3) fucosyltransferase), transcript variant X1
alpha-(1,3)-fucosyltransferase 11 isoform X2
alpha-(1,3)-fucosyltransferase 11 isoform X1
uncharacterized LOC121270766, transcript variant X1
uncharacterized LOC121270766, transcript variant X2
coiled-coil-helix-coiled-coil-helix domain containing 1
coiled-coil-helix-coiled-coil-helix domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger, SWIM-type containing 8, transcript variant X3
zinc finger, SWIM-type containing 8, transcript variant X2
zinc finger, SWIM-type containing 8, transcript variant X1
zinc finger, SWIM-type containing 8, transcript variant X4
zinc finger SWIM domain-containing protein 8 isoform X1
zinc finger SWIM domain-containing protein 8 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2a, transcript variant X1
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2a, transcript variant X3
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2a, transcript variant X2
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X2
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X3
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X1
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X6
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X4
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X4
calcium/calmodulin-dependent protein kinase type II delta chain isoform X2
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X3
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X7
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X5
nucleolar and coiled-body phosphoprotein 1, transcript variant X1
nucleolar and coiled-body phosphoprotein 1, transcript variant X2
nucleolar and coiled-body phosphoprotein 1 isoform X1
nucleolar and coiled-body phosphoprotein 1 isoform X2
2-hydroxyacylsphingosine 1-beta-galactosyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
2-hydroxyacylsphingosine 1-beta-galactosyltransferase-like, transcript variant X2
2-hydroxyacylsphingosine 1-beta-galactosyltransferase-like isoform X1
2-hydroxyacylsphingosine 1-beta-galactosyltransferase-like isoform X2
polymerase (RNA) III (DNA directed) polypeptide A, transcript variant X2
polymerase (RNA) III (DNA directed) polypeptide A, transcript variant X1
DNA-directed RNA polymerase III subunit RPC1 isoform X2
DNA-directed RNA polymerase III subunit RPC1 isoform X1
polymerase (RNA) III (DNA directed) polypeptide A, transcript variant X3
DNA-directed RNA polymerase III subunit RPC1 isoform X3